240 related articles for article (PubMed ID: 33208757)
1. The relationship between specialized pro-resolving lipid mediators, morbid obesity and weight loss after bariatric surgery.
Schulte F; Asbeutah AA; Benotti PN; Wood GC; Still C; Bistrian BR; Hardt M; Welty FK
Sci Rep; 2020 Nov; 10(1):20128. PubMed ID: 33208757
[TBL] [Abstract][Full Text] [Related]
2. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue.
Colas RA; Shinohara M; Dalli J; Chiang N; Serhan CN
Am J Physiol Cell Physiol; 2014 Jul; 307(1):C39-54. PubMed ID: 24696140
[TBL] [Abstract][Full Text] [Related]
3. Morbid obesity and type 2 diabetes alter intestinal fatty acid uptake and blood flow.
Koffert J; Ståhle M; Karlsson H; Iozzo P; Salminen P; Roivainen A; Nuutila P
Diabetes Obes Metab; 2018 Jun; 20(6):1384-1390. PubMed ID: 29352513
[TBL] [Abstract][Full Text] [Related]
4. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
Barden AE; Mas E; Croft KD; Phillips M; Mori TA
Am J Clin Nutr; 2015 Dec; 102(6):1357-64. PubMed ID: 26561623
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end-products in morbid obesity and after bariatric surgery: When glycemic memory starts to fail.
Sánchez E; Baena-Fustegueras JA; de la Fuente MC; Gutiérrez L; Bueno M; Ros S; Lecube A
Endocrinol Diabetes Nutr; 2017 Jan; 64(1):4-10. PubMed ID: 28440769
[TBL] [Abstract][Full Text] [Related]
6. Association of circulating proinflammatory marker, leucine-rich-α2-glycoprotein (LRG1), following metabolic/bariatric surgery.
Pek SLT; Cheng AKS; Lin MX; Wong MS; Chan EZL; Moh AMC; Sum CF; Lim SC; Tavintharan S
Diabetes Metab Res Rev; 2018 Oct; 34(7):e3029. PubMed ID: 29883055
[TBL] [Abstract][Full Text] [Related]
7. The effects of alcohol on plasma lipid mediators of inflammation resolution in patients with Type 2 diabetes mellitus.
Barden A; Shinde S; Phillips M; Beilin L; Mas E; Hodgson JM; Puddey I; Mori TA
Prostaglandins Leukot Essent Fatty Acids; 2018 Jun; 133():29-34. PubMed ID: 29789130
[TBL] [Abstract][Full Text] [Related]
8. Acute severe SARS COVID-19 patients produce pro-resolving lipids mediators and eicosanoids.
Regidor PA; De La Rosa X; Santos FG; Rizo JM; Gracia Banzo R; Silva RS
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6782-6796. PubMed ID: 34787883
[TBL] [Abstract][Full Text] [Related]
9. The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity.
Brix JM; Höllerl F; Kopp HP; Schernthaner GH; Schernthaner G
Int J Obes (Lond); 2012 Nov; 36(11):1412-7. PubMed ID: 22828946
[TBL] [Abstract][Full Text] [Related]
10. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin.
García de la Torre N; Rubio MA; Bordiú E; Cabrerizo L; Aparicio E; Hernández C; Sánchez-Pernaute A; Díez-Valladares L; Torres AJ; Puente M; Charro AL
J Clin Endocrinol Metab; 2008 Nov; 93(11):4276-81. PubMed ID: 18713823
[TBL] [Abstract][Full Text] [Related]
11. Metabolites and diabetes remission after weight loss.
Kwee LC; Ilkayeva O; Muehlbauer MJ; Bihlmeyer N; Wolfe B; Purnell JQ; Xavier Pi-Sunyer F; Chen H; Bahnson J; Newgard CB; Shah SH; Laferrère B
Nutr Diabetes; 2021 Feb; 11(1):10. PubMed ID: 33627633
[TBL] [Abstract][Full Text] [Related]
12. Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation.
Neuhofer A; Zeyda M; Mascher D; Itariu BK; Murano I; Leitner L; Hochbrugger EE; Fraisl P; Cinti S; Serhan CN; Stulnig TM
Diabetes; 2013 Jun; 62(6):1945-56. PubMed ID: 23349501
[TBL] [Abstract][Full Text] [Related]
13. Frontline Science: A reduction in DHA-derived mediators in male obesity contributes toward defects in select B cell subsets and circulating antibody.
Crouch MJ; Kosaraju R; Guesdon W; Armstrong M; Reisdorph N; Jain R; Fenton J; Shaikh SR
J Leukoc Biol; 2019 Aug; 106(2):241-257. PubMed ID: 30576001
[TBL] [Abstract][Full Text] [Related]
14. The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery.
Demyanets S; Kaun C; Kaider A; Speidl W; Prager M; Oravec S; Hohensinner P; Wojta J; Rega-Kaun G
Cardiovasc Diabetol; 2020 Feb; 19(1):26. PubMed ID: 32101157
[TBL] [Abstract][Full Text] [Related]
15. Comparison of changes in blood glucose, insulin resistance indices, and adipokine levels in diabetic and nondiabetic subjects with morbid obesity after laparoscopic adjustable gastric banding.
Urbanavičius V; Abalikšta T; Brimas G; Abraitienė A; Gogelienė L; Strupas K
Medicina (Kaunas); 2013; 49(1):9-14. PubMed ID: 23652711
[TBL] [Abstract][Full Text] [Related]
16. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.
Sell H; Divoux A; Poitou C; Basdevant A; Bouillot JL; Bedossa P; Tordjman J; Eckel J; Clément K
J Clin Endocrinol Metab; 2010 Jun; 95(6):2892-6. PubMed ID: 20375212
[TBL] [Abstract][Full Text] [Related]
17. Leukocytes from obese individuals exhibit an impaired SPM signature.
López-Vicario C; Titos E; Walker ME; Alcaraz-Quiles J; Casulleras M; Durán-Güell M; Flores-Costa R; Pérez-Romero N; Forné M; Dalli J; Clària J
FASEB J; 2019 Jun; 33(6):7072-7083. PubMed ID: 30840838
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-like protein 8/betatrophin as a new determinant of type 2 diabetes remission after bariatric surgery.
Ejarque M; Borlaug M; Vilarrasa N; Martinez-Perez B; Llauradó G; Megía A; Helland T; Gutierrez C; Serena C; Folkestad O; Nuñez-Roa C; Roche K; Casajoana A; Fradera R; González-Clemente JM; López M; Mohn AC; Nedrebø BG; Nogueiras R; Mellgren G; Fernø J; Fernández-Veledo S; Vendrell J
Transl Res; 2017 Jun; 184():35-44.e4. PubMed ID: 28347650
[TBL] [Abstract][Full Text] [Related]
19. Improved Magnesium Levels in Morbidly Obese Diabetic and Non-diabetic Patients After Modest Weight Loss.
Mikalsen SM; Bjørke-Monsen AL; Whist JE; Aaseth J
Biol Trace Elem Res; 2019 Mar; 188(1):45-51. PubMed ID: 29705834
[TBL] [Abstract][Full Text] [Related]
20. Prolonged experimental sleep disturbance affects the inflammatory resolution pathways in healthy humans.
Engert LC; Mullington JM; Haack M
Brain Behav Immun; 2023 Oct; 113():12-20. PubMed ID: 37369338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
